Search clinical trials for: aromatase inhibitor

Total 67764 results

Farin Amersi

Terminated

BREADS: Breast Adjuvant Diet Study

Breast Cancer

United States
University of Milano Bicocca

Active, not recruiting

Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7) (HERMIONE-7)

Advanced Breast Cancer

Italy
Pfizer

Active, not recruiting

Analysis of the Real-world Prescription Pattern of Palbociclib Combination Therapy With Aromatase Inhibitor as a First Line Therapy in Metastatic Breast Cancer Patients Using the National Health Insurance Claims Data in South Korea

Metastatic Breast Cancer

Korea, Republic of
Spanish Breast Cancer Research Group
Pfizer

Completed

Selective Neoadjuvant Treatment According to Immunohistochemical Subtype for HER2 Negative Breast Cancer Patients

Breast Cancer

Spain
Spanish Breast Cancer Research Group
Hoffmann-La Roche; German Breast Group

Completed

Bevacizumab + Endocrine Treatment vs Endocrine Treatment as First Line in Postmenopausal Women

Breast Cancer

Spain, Germany
Pfizer

Completed

Real-World Effectiveness of Palbociclib in Combination With an Aromatase Inhibitor

Metastatic Breast Cancer

United States
National Cancer Institute, Naples
University of Campania "Luigi Vanvitelli"

Active, not recruiting

HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer. (HOBOE)

Breast Cancer

Italy
Veru Inc.

Withdrawn

Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Pfizer

Completed

Patient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients Diagnosed With HR+/HER2 Advanced/Metastatic Breast Cancer on Palbociclib + Aromatase Inhibitor (AI) Combination Therapy

Breast Cancer

United States
Cairo University

Completed

Combined Chromium With Letrozole Versus Letrozole Only in Induction of Ovulation in Patients With Polycystic Ovary Syndrome

Polycystic Ovary Syndrome

Egypt
iOMEDICO AG
Pfizer

Completed

Study in Women With Advanced Breast Cancer Receiving Palbociclib With AI or Fulvestrant (INGE-B)

Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

Germany
Spanish Breast Cancer Research Group
AstraZeneca

Terminated

Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole

Breast Cancer

Spain
Fudan University
Jiangsu HengRui Medicine Co., Ltd.

Active, not recruiting

Pyrotinib, Dalpiciclib(SHR6390) and Endocrine Therapy in Subjects With Dual-receptor Positive(ER+/HER2+) Advanced Breast Cancer (PLEASURABLE)

Breast Cancer

China
Spanish Breast Cancer Research Group
Pfizer

Completed

Exemestane Versus Anastrozole as First Line Hormone Therapy in Postmenopausal Metastatic Breast Cancer Patients

Breast Cancer

Spain
Gynecologic Oncology Group
Novartis

Active, not recruiting

Ribociclib and Letrozole Treatment in Ovarian Cancer

Low Grade Serous Carcinoma

United States
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer

Breast Neoplasms | Arthralgia

United States
National Taiwan University Hospital
Merck Sharp & Dohme LLC

Terminated

Pembrolizumab and Exemestane/ Leuprolide in Premenopausal HR+/ HER2- Locally Advanced or Metastatic Breast Cancer (PEER)

Premenopausal Breast Cancer

Taiwan
Maastricht University Medical Center

Completed

Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast Cancer (DATA)

Breast Cancer

Netherlands
Nordic Society of Gynaecological Oncology - Clinical...
European Network of Gynaecological Oncological Trial Groups (ENGOT); Grupo... and other collaborators

Completed

Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer

Endometrial Cancer

Denmark
Novartis Pharmaceuticals

Completed

Treatment of Canadian Men and Pre/Peri/Post-menopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy (Treat ER+ight)

HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer

Canada
Calithera Biosciences, Inc

Completed

Sapanisertib in Combination With Fulvestrant in Women With Advanced or Metastatic Breast Cancer After Aromatase Inhibitor Therapy

Breast Neoplasms

United States, Spain
Calithera Biosciences, Inc

Completed

Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast Cancer

Breast Cancer

United States, Belgium, France
Services Institute of Medical Sciences, Pakistan

Completed

Letrozole vs Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovarian Syndrome

Polycystic Ovary Syndrome | Infertility

Pakistan
MedSIR

Completed

Palbociclib in Combination With Fulvestrant or Letrozole in Patients With ER+, HER2- Advanced Breast Cancer (PARSIFAL)

Metastatic Breast Cancer

Spain, Czechia, France, Germany, Italy, Russian Federation, United Kingdom
iOMEDICO AG
Novartis Pharmaceuticals

Completed

Ribociclib and Endocrine Therapy or Chemotherapy With or Without Bevacizumab for Metastatic Breast Cancer in First Line (RIBBIT)

Breast Cancer | Hormone Receptor Positive Tumor | HER 2 Negative Breast Cancer

Germany
Hoffmann-La Roche
Norwegian Radium Hospital

Completed

A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer

Breast Cancer

Norway
University Hospital, Ghent

Completed

Evaluation of Arthroscopic Reconstruction of the Anterior Cruciate Ligament by One Night Hospital Stay or by Day Surgery: a Randomised, Prospective Clinical Trial

Rupture of the Anterior Cruciate Ligament With Instability of the Knee Joint

Belgium
Shanghai Jiao Tong University School of Medicine

Completed

Safety of OFS Combined With AI Endocrine Therapy in Chinese Premenopausal Breast Cancer Patients (SEAT)

Breast Cancer

China
Memorial Sloan Kettering Cancer Center
Johns Hopkins University; Novartis Pharmaceuticals; University of California,... and other collaborators

Completed

Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)

Fibrolamellar Carcinoma | Fibrolamellar Liver Cancer

United States
Medical College of Wisconsin

Withdrawn

Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer

Advanced Breast Cancer | Solid Tumor

United States
Oregon Health and Science University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Active, not recruiting

Regulation of Cortisol Metabolism and Fat Patterning

Obesity | Menopausal Syndrome

United States
Weill Medical College of Cornell University

Completed

RCT of Fixed vs Titrated Letrozole in Breast Cancer Patient Undergoing IVF

Breast Cancer | Infertility

United States
Southwest Oncology Group
National Cancer Institute (NCI); National Center for Complementary and Integrative...

Completed

S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast Cancer

Pain | Breast Cancer

United States
Assiut University

Withdrawn

Different Protocols in Ovarian Stimulation in Intracytoplasmic Sperm Injection Cycles

ART

Egypt
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment

Breast Cancer | Arthralgia | Hot Flashes | Sexual Dysfunction | Musculoskeletal Complications

United States, Puerto Rico
Trans Tasman Radiation Oncology Group

Active, not recruiting

STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing) (STARS)

Breast Cancer

Australia, New Zealand
European Organisation for Research and Treatment...
Sanofi; Novartis; Roche Pharma AG; Breast International Group; Agendia

Completed

Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes (MINDACT)

Breast Cancer

Netherlands
Dawn L. Hershman

Completed

Glucosamine and Chondroitin for Aromatase Inhibitor Induced Joint Symptoms in Women With Breast Cancer

Breast Cancer | Joint Pain

United States
Novartis Pharmaceuticals

Completed

Ribociclib in Combination With Non-steroidal Aromatase Inhibitors in Patients With Advanced Breast Cancer

Breast Cancer

Brazil
SOLTI Breast Cancer Research Group
Pfizer

Completed

Palbociclib Plus Letrozole in Hormone Receptor Positive Residual Disease After Neoadjuvant Chemotherapy (PROMETEO II)

Breast Cancer

Spain
University of Alabama at Birmingham
Genentech, Inc.; Breast Cancer Research Foundation

Completed

Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer

Breast Cancer | Breast Neoplasm | Cancer of the Breast

United States
Seoul National University Hospital

Active, not recruiting

Breast Density Change Predicting Response to Adjuvant Aromatase Inhibitor (DEAR)

Invasive Breast Cancer | Estrogen Receptor Positive Breast Cancer

Korea, Republic of
Pfizer

Completed

Comparative Real World Tumor Response in Pre-menopausal Metastatic Breast Cancer Patients Treated With Palbociclib + Aromatase Inhibitor or Aromatase Inhibitor Alone

Metastatic Breast Cancer

United States
University Medical Center Groningen

Completed

Palbociclib and FES PET

Breast Cancer

Netherlands
Ottawa Hospital Research Institute

Completed

Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT) (REaCT-RETT)

Early-stage Breast Cancer

Canada
Qamar Khan
Novartis Pharmaceuticals

Active, not recruiting

Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer (FELINE)

Breast Cancer

United States
Jonsson Comprehensive Cancer Center
Bayer; Translational Research in Oncology-U.S. Inc. (TRIO-US)

Terminated

Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancer

Stage I Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative and other conditions

United States
UNICANCER
Novartis; Fondation ARC

Completed

Molecular Alterations Associated With Resistance to Endocrine Therapy and Impacting Treatment With mTOR Inhibitor (SAFIR-TOR)

Metastatic Breast Cancer

France
Indiana University

Completed

Pilot Study of a an App to Improve Medication Adherence in Breast Cancer Survivors Receiving AIs

Breast Cancer | DCIS

United States
Massachusetts General Hospital
National Institute on Aging (NIA)

Completed

Anastrozole Administration in Elderly Hypogonadal Men

Hypogonadism

United States

3

Subscribe